임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
16건 표시
- 2상모집 중· Myasthenia Gravis, GeneralizedA Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
리드: 버텍스
- 1상모집 중· Cystic FibrosisDose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
리드: 버텍스
- 1상모집 중· Cystic FibrosisDose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
리드: 버텍스
- 3상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 2상모집 중· Autosomal Dominant Polycystic Kidney Disease (ADPKD)Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
리드: 버텍스
- 2/3상모집 중· Primary Membranous NephropathyEvaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
리드: 버텍스
- 2상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 3상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 1/2상모집 중· Myotonic Dystrophy Type 1 (DM1)A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
리드: 버텍스
- 2/3상모집 중· Proteinuric Kidney DiseasePhase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
리드: 버텍스
- 3상모집 중· Diabetes Mellitus, Type 1A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
리드: 버텍스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.